Drugs / Normobaric Hyperoxia
Normobaric Hyperoxia
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05351073 | Jan → Jul 2022 | ischemic stroke | Capital Medical University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Normobaric Hyperoxia | “Normobaric Hyperoxia (NBO)” NCT05351073 ↗ |
| Known as | NBO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05351073 ↗ |
| Known as | Normobaric Oxygen | “normobaric oxygen therapy (NBO)” NCT05351073 ↗ |
| Route | Inhaled | “Oxygen inhalation through a mask” NCT05351073 ↗ |